Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 488 Leukemia 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 198 Lymphoma 133 Myelodysplastic Syndromes 95 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 74 Leukemia, Monocytic, Acute 74 Congenital Abnormalities 73 Leukemia, Myelomonocytic, Acute 71 Leukemia, Erythroblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Leukemia, Megakaryoblastic, Acute 63 Recurrence 59 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Multiple Myeloma 20 Leukemia, Eosinophilic, Acute 19

Interventions

Docetaxel 257 Prednisone 199 enzalutamide 164 Leuprolide 159 Radiotherapy 151 Abiraterone Acetate 140 Magnetic Resonance Spectroscopy 137 bicalutamide 115 Goserelin 114 Androgen Antagonists 101 Radiosurgery 96 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 95 apalutamide 78 gallium 68 PSMA-11 66 abiraterone 65 Specimen Handling 65 darolutamide 55 Gonadotropin-Releasing Hormone 53 Biopsy 52 Surveys and Questionnaires 51 Radiation 51 Brachytherapy 49 cabazitaxel 46 Triptorelin Pamoate 46 Standard of Care 44 pembrolizumab 43 luprolide acetate gel depot 42 Zoledronic Acid 41 Radiotherapy, Intensity-Modulated 41 Carboplatin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00480090 2019-02-15

SLAP

University Health Network, Toronto

Phase 2 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡